NO20060429L - DNA-baserte aptamerer for human Katepsin G - Google Patents

DNA-baserte aptamerer for human Katepsin G

Info

Publication number
NO20060429L
NO20060429L NO20060429A NO20060429A NO20060429L NO 20060429 L NO20060429 L NO 20060429L NO 20060429 A NO20060429 A NO 20060429A NO 20060429 A NO20060429 A NO 20060429A NO 20060429 L NO20060429 L NO 20060429L
Authority
NO
Norway
Prior art keywords
katepsin
dna
human
based aptamers
aptamers
Prior art date
Application number
NO20060429A
Other languages
English (en)
Inventor
Roberto Porta
Manlio Palumbo
Laura Iris Ferro
Barbara Gatto
Rodolfo Pescador
Original Assignee
Gentium Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentium Spa filed Critical Gentium Spa
Publication of NO20060429L publication Critical patent/NO20060429L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/34—Spatial arrangement of the modifications
    • C12N2310/343—Spatial arrangement of the modifications having patterns, e.g. ==--==--==--

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Det foreliggende forskningsarbeid er rettet mot identifiseringen av ikke-peptidinhibitorer av Katepsin G kjeimetegnet ved høye nivåer av selektivitet og som effektivt kan anvendes i behandlingen og profylaksen av inflammatoriske hendelser og prokoaguleringsbetingelser. Katepsin G-inhiberende aptamerer ifølge oppfinnelsen består av lineære DNA eller polynukleotidsekvenser med en kjedelengde på i det minste 60 nukleotider og som i det vesentiige ikke er utsatt for effektiv baseparing.
NO20060429A 2003-06-30 2006-01-26 DNA-baserte aptamerer for human Katepsin G NO20060429L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03425428A EP1493810A1 (en) 2003-06-30 2003-06-30 DNA-based aptamers for human cathepsin G
PCT/EP2004/006599 WO2005003347A2 (en) 2003-06-30 2004-06-18 Dna-based aptamers for human cathepsin g

Publications (1)

Publication Number Publication Date
NO20060429L true NO20060429L (no) 2006-01-26

Family

ID=33427291

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060429A NO20060429L (no) 2003-06-30 2006-01-26 DNA-baserte aptamerer for human Katepsin G

Country Status (16)

Country Link
US (2) US20060148745A1 (no)
EP (3) EP1493810A1 (no)
JP (2) JP2007506413A (no)
KR (1) KR20060035624A (no)
CN (1) CN1816625A (no)
AU (1) AU2004254014B2 (no)
BR (1) BRPI0412081A (no)
CA (1) CA2528686A1 (no)
IL (1) IL172407A0 (no)
IS (1) IS8176A (no)
MX (1) MXPA05013800A (no)
NO (1) NO20060429L (no)
RS (1) RS20050955A (no)
RU (1) RU2360000C2 (no)
WO (1) WO2005003347A2 (no)
ZA (1) ZA200510093B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI482857B (zh) * 2013-10-21 2015-05-01 Nat Univ Tsing Hua 針對糖化血紅素及血紅素具有高專一性的適合體及其應用
EP3193906B1 (en) * 2014-09-18 2020-11-11 The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of Holy and Undiv. Trinity of Queen Elizabeth near Dublin Use of peptide inhibitors of il-36 proteolytic processing for the treatment and/or reduction of inflammation
RU2683868C1 (ru) * 2018-11-30 2019-04-02 Акционерное общество "Молочный комбинат "Ставропольский" Способ производства молочного сахара

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5475096A (en) 1990-06-11 1995-12-12 University Research Corporation Nucleic acid ligands
JPH06508022A (ja) * 1991-02-21 1994-09-14 ギリアド　サイエンシズ，インコーポレイテッド 生体分子に特異的なアプタマーおよび生産方法
DE19543750C2 (de) * 1995-11-24 1997-10-23 Crinos Industria Farmaco Cathepsin G inhibierende Aptamere
ATE383172T1 (de) * 1996-05-20 2008-01-15 Us Gov Health & Human Serv Oligonukleotide welche spezifisch retrovirale nukleokapsid-proteine binden
WO2000011446A2 (en) * 1998-08-21 2000-03-02 University Of Virginia Patent Foundation Signal generating oligonucleotide-based biosensor
AUPQ051099A0 (en) * 1999-05-24 1999-06-17 Tachas, George Dr Novel products and processes in treatment and/or prophylaxis

Also Published As

Publication number Publication date
KR20060035624A (ko) 2006-04-26
US7838506B2 (en) 2010-11-23
US20080176814A1 (en) 2008-07-24
MXPA05013800A (es) 2006-06-27
WO2005003347A2 (en) 2005-01-13
IS8176A (is) 2005-12-12
JP2007506413A (ja) 2007-03-22
US20060148745A1 (en) 2006-07-06
IL172407A0 (en) 2006-04-10
EP2236609A2 (en) 2010-10-06
CA2528686A1 (en) 2005-01-13
EP2236609A3 (en) 2011-07-20
RU2360000C2 (ru) 2009-06-27
AU2004254014A1 (en) 2005-01-13
BRPI0412081A (pt) 2006-09-05
ZA200510093B (en) 2008-04-30
AU2004254014B2 (en) 2010-06-10
RU2006102521A (ru) 2006-06-27
JP2011078414A (ja) 2011-04-21
EP1618196A2 (en) 2006-01-25
CN1816625A (zh) 2006-08-09
EP1493810A1 (en) 2005-01-05
WO2005003347A3 (en) 2005-09-15
RS20050955A (en) 2008-06-05

Similar Documents

Publication Publication Date Title
ATE459615T1 (de) 2-pyridonderivate zur behandlung von krankheiten oder leiden, bei denen eine inhibierung der aktivität der neutrophilen elastase von nutzen ist
LU93072I2 (fr) Inhibiteur de la protéinase alpha-1 humaine
HK1073467A1 (en) Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
NO20080965L (no) Cykloheksylaminisokinolonderivater som Rho-kinaseinhibotorer
DE60310582D1 (de) 2,5-dioxoimidazolidin-4-ylacetamide und analoga als inhibitoren von metalloproteinase mmp12
NO20062561L (no) Kinoliner nyttige for behandling av kardiovaskulaere sykdommer
NO20083032L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av mani og bipolar forstyrrelse
NO20082120L (no) Behandling og forebyggelse av mikroangiopati
BRPI0408922B1 (pt) processo para o tratamento termomecánico de aço.
DE50309356D1 (de) tung von Werkstücken
NO20060429L (no) DNA-baserte aptamerer for human Katepsin G
DE60134009D1 (de) Verwendung von il-18 inhibitoren zur behandlung und/oder prävention von atherosklerose
DE602004020734D1 (de) Derivate von piperazine-2-carboxamide
DE60129330D1 (de) Verwendung von cox-2 inhibitoren als immunostimulantien zur behandlung von hiv oder aids
SE9704543D0 (sv) New compounds
DE60232962D1 (de) Verfahren zur reduzierung des stotterns bei der mikrosatellitenamplifikation mittels sorbit
WO2009130615A3 (de) Verwendung von deuteriumoxid als elastase-inhibitor
DE602004028493D1 (de) Isochinolinon-kaliumkanalinhibitoren
WO2005039494A3 (en) Inhibitors of rnase p proteins as antibacterial compounds
SE0001803D0 (sv) New compounds i
EE200300582A (et) IL-18 inhibiitorite kasutamine kesknärvisüsteemi kahjustuste raviks või ennetamiseks
NO20073717L (no) Fenylmetanonderivater og deres anvendelse som glycin-transportor-1-inhibitorer
IL160068A0 (en) Mew mandelic acid derivatives and their use as thrombin inhibitors
SE0302253D0 (sv) Lipase-colipase inhibitor
NO20051468L (no) Behandling av ikke-allergisk rhinitt med selektive fosfodiesterase-4-inhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application